CN105535051A - Pharmaceutical preparation for preventing and treating toxoplasmosis of pigs and preparation method of pharmaceutical preparation - Google Patents
Pharmaceutical preparation for preventing and treating toxoplasmosis of pigs and preparation method of pharmaceutical preparation Download PDFInfo
- Publication number
- CN105535051A CN105535051A CN201610117167.5A CN201610117167A CN105535051A CN 105535051 A CN105535051 A CN 105535051A CN 201610117167 A CN201610117167 A CN 201610117167A CN 105535051 A CN105535051 A CN 105535051A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical preparation
- sodium
- preparation
- takes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Abstract
The invention discloses a pharmaceutical preparation for preventing and treating toxoplasmosis of pigs. The pharmaceutical preparation comprises following components in parts by weight through compatibility: 8-20 parts of doxycycline hydrochloride, 10-20 parts of sulfamonomethoxine sodium or sufisomezole, 1-4 parts of sulfatrimethoxine sodium or sulfadimethoxine sodium, 3-6 parts of fructooligosaccharides, 20-40 parts of anhydrous glucose, 20-30 parts of medical stone, 5-10 parts of Chinese thorowax roots, 4-10 parts of Wolfiporia extensa and 5-10 parts of pine needle meal. The invention further discloses a preparation method of the pharmaceutical preparation. According to mutual compatibility of the components of the pharmaceutical preparation, medicine absorption is promoted, the effects of the medicines are enhanced, toxic and side effects are reduced, and meanwhile, the preparation has the functions of protection of the liver and the kidney, antibacterial performance, abatement of fever, promotion of growth of normal flora in intestines and enhancement of the body immunity functions.
Description
Technical field
The present invention relates to the technical field of veterinary drug preparation, refer in particular to a kind of pharmaceutical preparation preventing and treating swine toxoplasmosis, and relevant with its preparation method.
Background technology
Swine toxoplasmosis, is also called tokoplasmosis or toxoplasmosis, is the protozoacide being caused infecting both domestic animals and human by Toxoplasmosis animal and human.Primary disease with high heat, to breathe and the miscarriage of neurological symptom, animal dead and pregnant animal, stillborn fetus, fetal anomaly is for principal character.Toxoplasmosis is that a kind of parasitic protozoa of universal Zoonosis is sick, extensively exists in domestic animal and wild animal.Toxoplasma is a kind of many hosts protozoon, not tight to the selection of intermediate host, there will be a known 200 many animals, comprises mammal, birds and the mankind etc. and all can be used as intermediate host.Primary disease be mainly in 3 ~ 4 the monthly age pig; Though without obviously seasonal, also not climate restriction, hot season autumn in summer of some place 6 ~ JIUYUE is multiple.Fulminant type, acute can be divided into according to popular form, sporadicly distribute and inapparent infection.Primary disease fulminant type is within a short time, and can make most of live pig morbidity on whole pig farm, mortality rate can reach more than 60%, causes serious economic loss to pig industry.Infect this after being ill, the immunity degradation of pig, other antibacterials of easy secondary or viral disease, toxoplasma is only responsive to sulfonamides, and to other antibiotic ineffective, and one of them serious side effect of sulfonamides is toxic to kidney, affect the excretion of infected animal, cause that sb.'s illness took a turn for the worse further.In addition, it is absolutely useless that infected animal understands appetite usually, and after from infecting to curing, recovery has a strong impact on the growth promoter of animal during this period of time, causes weight loss serious, increase aquaculture cost further.
Summary of the invention
For solving the problem, the object of the present invention is to provide a kind of pharmaceutical preparation of novel control swine toxoplasmosis, the mutual compatibility of each component in this formula, promote drug absorption, strengthen its effect, reduce toxic and side effects, have to protect the liver simultaneously and protect kidney, the antibacterial growth of bringing down a fever, promoting enteral normal flora, the effect of enhancing human body immunity function.
The present invention also aims to the preparation method of the pharmaceutical preparation that a kind of novel control swine toxoplasmosis is provided.
For reaching above-mentioned purpose, solution of the present invention is:
A kind of pharmaceutical preparation of novel control swine toxoplasmosis, formulated by weight by following compatibility: doxycycline hydrochloride 8-20 part, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole 10-20 part, trimethoxy pyrimidine sodium or SDM sodium 1-4 part, oligofructose 3-6 part, anhydrous glucose 20-40 part, Maifanitum 20-30 part, Radix Bupleuri 5-10 part, Poria 4-10 part, pine needle powder 5-10 part.Wherein, pine needle powder is the Folium Pini dried at dry place, pulverizes 80 mesh sieves, below water content 3wt%.
A preparation method for the pharmaceutical preparation of novel control swine toxoplasmosis, comprises the following steps:
Step one, takes Maifanitum, Radix Bupleuri, Poria, pine needle powder, micronizing, crosses 150 mesh sieves, makes pharmaceutical carrier;
Step 2, takes doxycycline hydrochloride, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole, trimethoxy pyrimidine sodium or SDM sodium, oligofructose, abundant mix homogeneously;
Step 3, by the mixture of step one and the abundant mix homogeneously of the mixture of step 2;
Step 4, takes anhydrous glucose, stirs, obtain pharmaceutical preparation of the present invention together with step 3 gained mixture.
After adopting such scheme, the pharmaceutical preparation of a kind of novel control swine toxoplasmosis of the present invention is made up of Western medicine component and carrier component, wherein, western medicine composition is broad spectrum antibiotic, cooperatively interact, its effect strengthens more than several times, have very strong antibacterial, sterilize, kill the effects such as toxoplasma; Vehicle component has heat-clearing and toxic substances removing; bring down a fever, adsorb pathogenic bacterium in intestinal and toxin; protection intestinal mucosa; for intestinal beneficial microbes flora provides trophic factors, safeguards the ecological balance of intestinal beneficial flora; regulate gastrointestinal function, improve anti-stress ability, strengthen immunologic function, protect the liver effects such as protecting kidney.Therefore, compared with prior art, have the following advantages:
One, there is complementary action in carrier of the present invention and the mutual compatibility of Western medicine, have efficient, quick-acting, safeguard the effect such as enteral microecological balance, enhancing human body immunity power;
Two, the western medicine composition of employing, has the effect of very strong antibacterial, the toxoplasma etc. that sterilizes, kills;
Three, the vehicle component of employing, the pathogenic bacterium in absorption intestinal and toxin, protection intestinal mucosa, for intestinal beneficial microbes flora provides trophic factors, safeguards the ecological balance of intestinal beneficial flora, improves anti-stress ability;
Four, can protect the liver and protect kidney, reduce the kidney toxic and side effects that western medicine composition causes, safe and reliable;
Five, remarkable to the prevention effect of swine toxoplasmosis;
Meanwhile, a kind of preparation method of pharmaceutical preparation of novel control swine toxoplasmosis is easy, easily applies.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in further detail.
Embodiment one
A pharmaceutical preparation for novel control swine toxoplasmosis, formulated by weight by following compatibility: 1 part, doxycycline hydrochloride 8 parts, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole 10 parts, trimethoxy pyrimidine sodium or SDM sodium, oligofructose 3 parts, anhydrous glucose 20 parts, Maifanitum 20 parts, Radix Bupleuri 5 parts, 4 parts, Poria, pine needle powder 5 parts.
A preparation method for the pharmaceutical preparation of novel control swine toxoplasmosis, comprises the following steps:
Step one, takes Maifanitum, Radix Bupleuri, Poria, pine needle powder, micronizing, crosses 150 mesh sieves, makes pharmaceutical carrier;
Step 2, takes doxycycline hydrochloride, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole, trimethoxy pyrimidine sodium or SDM sodium, oligofructose, abundant mix homogeneously;
Step 3, by the mixture of step one and the abundant mix homogeneously of the mixture of step 2;
Step 4, takes anhydrous glucose, stirs, obtain pharmaceutical preparation of the present invention together with step 3 gained mixture.
Embodiment two
A pharmaceutical preparation for novel control swine toxoplasmosis, formulated by weight by following compatibility: doxycycline hydrochloride 8 parts, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole 10 parts, trimethoxy pyrimidine sodium or SDM sodium 1-4 part, oligofructose 3 parts, anhydrous glucose 40 parts, Maifanitum 30 parts, Radix Bupleuri 10 parts, 10 parts, Poria, pine needle powder 10 parts.
A preparation method for the pharmaceutical preparation of novel control swine toxoplasmosis, comprises the following steps:
Step one, takes Maifanitum, Radix Bupleuri, Poria, pine needle powder, micronizing, crosses 150 mesh sieves, makes pharmaceutical carrier;
Step 2, takes doxycycline hydrochloride, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole, trimethoxy pyrimidine sodium or SDM sodium, oligofructose, abundant mix homogeneously;
Step 3, by the mixture of step one and the abundant mix homogeneously of the mixture of step 2;
Step 4, takes anhydrous glucose, and being mixed with step 3 gained stirs, and obtains pharmaceutical preparation of the present invention.
Embodiment three
A pharmaceutical preparation for novel control swine toxoplasmosis, formulated by weight by following compatibility: 4 parts, doxycycline hydrochloride 20 parts, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole 20 parts, trimethoxy pyrimidine sodium or SDM sodium, oligofructose 3 parts, anhydrous glucose 30 parts, Maifanitum 25 parts, Radix Bupleuri 8 parts, 8 parts, Poria, pine needle powder 10 parts.
A preparation method for the pharmaceutical preparation of novel control swine toxoplasmosis, comprises the following steps:
Step one, takes Maifanitum, Radix Bupleuri, Poria, pine needle powder, micronizing, crosses 150 mesh sieves, makes pharmaceutical carrier;
Step 2, takes doxycycline hydrochloride, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole, trimethoxy pyrimidine sodium or SDM sodium, oligofructose, abundant mix homogeneously;
Step 3, by the mixture of step one and the abundant mix homogeneously of the mixture of step 2;
Step 4, takes anhydrous glucose, and being mixed with step 3 gained stirs, and obtains pharmaceutical preparation of the present invention.
Embodiment four
A kind of pharmaceutical preparation of novel control swine toxoplasmosis, formulated by weight by following compatibility: doxycycline hydrochloride 16 parts, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole 15 parts, trimethoxy pyrimidine sodium or 2 parts, SDM sodium, oligofructose 4 parts, anhydrous glucose 30 parts, Maifanitum 30 parts, Radix Bupleuri 10 parts, 10 parts, Poria, pine needle powder 10 parts.
A preparation method for the pharmaceutical preparation of novel control swine toxoplasmosis, comprises the following steps:
Step one, takes Maifanitum, Radix Bupleuri, Poria, pine needle powder, micronizing, crosses 150 mesh sieves, makes pharmaceutical carrier;
Step 2, takes doxycycline hydrochloride, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole, trimethoxy pyrimidine sodium or SDM sodium, oligofructose, abundant mix homogeneously;
Step 3, by the abundant mix homogeneously of mixture of the mixture step 2 of step one;
Step 4, takes anhydrous glucose, stirs, obtain pharmaceutical preparation of the present invention together with step 3 gained mixture.
Embodiment five
A kind of pharmaceutical preparation of novel control swine toxoplasmosis, formulated by weight by following compatibility: doxycycline hydrochloride 20 parts, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole 15 parts, trimethoxy pyrimidine sodium or 4 parts, SDM sodium, oligofructose 5 parts, anhydrous glucose 35 parts, Maifanitum 20 parts, Radix Bupleuri 7 parts, 7 parts, Poria, pine needle powder 5 parts.
A preparation method for the pharmaceutical preparation of novel control swine toxoplasmosis, comprises the following steps:
Step one, takes Maifanitum, Radix Bupleuri, Poria, pine needle powder, micronizing, crosses 150 mesh sieves, makes pharmaceutical carrier;
Step 2, takes doxycycline hydrochloride, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole, trimethoxy pyrimidine sodium or SDM sodium, oligofructose, abundant mix homogeneously;
Step 3, by the mixture of step one and the abundant mix homogeneously of the mixture of step 2;
Step 4, takes anhydrous glucose, stirs, obtain pharmaceutical preparation of the present invention together with step 3 gained mixture.
Embodiment six
A kind of pharmaceutical preparation of novel control swine toxoplasmosis, formulated by weight by following compatibility: doxycycline hydrochloride 10 parts, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole 10 parts, trimethoxy pyrimidine sodium or 2 parts, SDM sodium, oligofructose 3 parts, anhydrous glucose 40 parts, Maifanitum 20 parts, Radix Bupleuri 6 parts, 8 parts, Poria, pine needle powder 8 parts.
A preparation method for the pharmaceutical preparation of novel control swine toxoplasmosis, comprises the following steps:
Step one, takes Maifanitum, Radix Bupleuri, Poria, pine needle powder, micronizing, crosses 150 mesh sieves, makes pharmaceutical carrier;
Step 2, takes doxycycline hydrochloride, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole, trimethoxy pyrimidine sodium or SDM sodium, oligofructose, abundant mix homogeneously;
Step 3, by the mixture of step one and the abundant mix homogeneously of the mixture of step 2;
Step 4, takes anhydrous glucose, stirs, obtain pharmaceutical preparation of the present invention together with step 3 gained mixture.
Be below the application example of pharmaceutical preparation of the present invention:
One, application example 1
Scale pig farm, Period In Maoming city, in July, 2014, there is loss of appetite in 300 bull growing and fattening pigs, part pig dyspnea, and in ventral breathing, with cough, body temperature is many at 40 DEG C ~ 41.5 DEG C, delays and does not move back.There are ecchymosis in part pig lower body part and ear.Through the laboratory diagnosis of Maoming City Disease Control and Prevention Center, be diagnosed as swine toxoplasmosis.
Select disease pig 240, be divided into 8 groups at random, be respectively test A, B, C, D, E, F, drug control group, blank group, often organize 30.Wherein, the preparation of the A group mixed feeding embodiment of the present invention one is tested; The preparation of the test B group mixed feeding embodiment of the present invention two; The preparation of the test C group mixed feeding embodiment of the present invention three, the preparation of the test D group mixed feeding embodiment of the present invention four, the preparation of the test E group mixed feeding embodiment of the present invention five, the preparation of the test F group mixed feeding embodiment of the present invention six, drug control group mixed feeding doxycycline hydrochloride+compound sulfonamide pregnancy preparation, often organize and all add corresponding medicine 1kg/ ton feedstuff, feed continuously 5; Blank group does not add any medicine.
Observe in seven days and the Clinical symptoms of recording laboratory animal, judge therapeutic effect.
Index of assessment of curative effect
Cure rate: clinical symptoms disappears completely after medication treatment, spirit and diet recover normal for curing.
Effective percentage: the animal of curing after medication treatment and symptom have and obviously alleviate, and are judged to be effectively.
Inefficiency: through medication treatment after clinical symptoms do not disappear, the state of an illness do not take a turn for the better and treatments period because of being judged to of primary disease death invalid.
Clinical test results is in table 1
Table 1 pharmaceutical preparation of the present invention is to the therapeutic effect of swine toxoplasmosis
| Group | A group | B group | C group | D group | E group | F group | Drug control group | Matched group |
| Case load | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 |
| Cure rate % | 80.00% | 83.33% | 86.67% | 93.33% | 100% | 100% | 50% | 0% |
| Effective percentage % | 86.67% | 90.00% | 93.34% | 96.66% | 100% | 100% | 60% | 10.00% |
| Inefficiency % | 13.33% | 10.00% | 6.66% | 3.34% | 0% | 0% | 40% | 90.00% |
As shown in Table 1, pharmaceutical preparation of the present invention, compared with doxycycline hydrochloride+compound sulfonamide pregnancy hybrid medicine preparation, has significant curative effect to treatment swine toxoplasmosis; And after curing, appetite and speed of weight increment recover all very fast.Consider from preparation cost, embodiment six is best of breed of the present invention.
Two, the experiment of invention formulation prevention swine toxoplasmosis
Select the scale pig farm having toxoplasma to exist through test in laboratory, use invention formulation embodiment six, select the piglets 90 that age in days is close, be divided into 3 groups at random, be respectively A group, drug control group, matched group, often organize 30.Wherein, the preparation of the test A group mixed feeding embodiment of the present invention six, drug control group mixed feeding doxycycline hydrochloride+compound sulfonamide pregnancy pharmaceutical preparation, often organize and all add corresponding medicine 1kg/ ton feedstuff, feed continuously 5, matched group does not add any medicine, selects 30 toxoplasmas else and is detected as feminine gender and makes normal healthy controls group.Result of the test is as table 2.
Table 2 pharmaceutical preparation of the present invention is to the preventive effect of swine toxoplasmosis
| Group | A group | Drug control group | Matched group | Normal healthy controls group |
| Test pig number | 30 | 30 | 30 | 30 |
| Morbidity number | 0 | 12 | 25 | 0 |
| Sickness rate % | 0% | 40% | 83.33% | 0% |
From table 1, table 2, pharmaceutical preparation of the present invention, compared with doxycycline hydrochloride+compound sulfonamide pregnancy medicament mixed preparation, has significant curative effect to control swine toxoplasmosis, regularly uses the sickness rate that significantly can reduce pig farm toxoplasmosis, significantly improve benefit of raising pigs, be worthy of popularization.
Claims (2)
1. prevent and treat the pharmaceutical preparation of swine toxoplasmosis for one kind, it is characterized in that: formulated by weight by following compatibility: doxycycline hydrochloride 8-20 part, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole 10-20 part, trimethoxy pyrimidine sodium or SDM sodium 1-4 part, oligofructose 3-6 part, anhydrous glucose 20-40 part, Maifanitum 20-30 part, Radix Bupleuri 5-10 part, Poria 4-10 part, pine needle powder 5-10 part.
2. a kind of pharmaceutical preparation preventing and treating swine toxoplasmosis as claimed in claim 1, is characterized in that preparation method comprises the following steps:
Step one, takes Maifanitum, Radix Bupleuri, Poria, pine needle powder, micronizing, crosses 150 mesh sieves, makes pharmaceutical carrier;
Step 2, takes doxycycline hydrochloride, sulfobutyl ether-β-cyclodextrin sodium or sulfamethoxazole, trimethoxy pyrimidine sodium or SDM sodium, oligofructose, abundant mix homogeneously;
Step 3, by the mixture of step one and the abundant mix homogeneously of the mixture of step 2;
Step 4, takes anhydrous glucose, stirs, obtain pharmaceutical preparation together with step 3 gained mixture.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610117167.5A CN105535051A (en) | 2016-03-02 | 2016-03-02 | Pharmaceutical preparation for preventing and treating toxoplasmosis of pigs and preparation method of pharmaceutical preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610117167.5A CN105535051A (en) | 2016-03-02 | 2016-03-02 | Pharmaceutical preparation for preventing and treating toxoplasmosis of pigs and preparation method of pharmaceutical preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105535051A true CN105535051A (en) | 2016-05-04 |
Family
ID=55814976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610117167.5A Pending CN105535051A (en) | 2016-03-02 | 2016-03-02 | Pharmaceutical preparation for preventing and treating toxoplasmosis of pigs and preparation method of pharmaceutical preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105535051A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101816663A (en) * | 2009-02-26 | 2010-09-01 | 河南惠通天下动物药业有限公司 | Medicinal composition and injecta for curing avian toxoplasmosis, and preparation method thereof |
| CN102727693A (en) * | 2012-06-20 | 2012-10-17 | 青岛绿曼生物工程有限公司 | Compound propolis composition used for treating swine toxoplasmosis, and preparation method thereof |
| CN104431347A (en) * | 2014-09-30 | 2015-03-25 | 全椒县大地种植专业合作社 | Feed additive for preventing and treating swine toxoplasmosis |
-
2016
- 2016-03-02 CN CN201610117167.5A patent/CN105535051A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101816663A (en) * | 2009-02-26 | 2010-09-01 | 河南惠通天下动物药业有限公司 | Medicinal composition and injecta for curing avian toxoplasmosis, and preparation method thereof |
| CN102727693A (en) * | 2012-06-20 | 2012-10-17 | 青岛绿曼生物工程有限公司 | Compound propolis composition used for treating swine toxoplasmosis, and preparation method thereof |
| CN104431347A (en) * | 2014-09-30 | 2015-03-25 | 全椒县大地种植专业合作社 | Feed additive for preventing and treating swine toxoplasmosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103893272B (en) | A kind of pharmaceutical composition and preparation method for the treatment of livestock dysentery | |
| US20160143321A1 (en) | Feed additive for swine and feed composition containing the same | |
| CN102302599A (en) | Chinese medicinal composition for preventing and treating porcine diarrhea | |
| CN103006792A (en) | Veterinary drug for preventing livestock bowel diseases, preparation method of drug, and feed | |
| EA017656B1 (en) | Composition for prevention and treatment of pig dysentery | |
| CN103006916A (en) | Pure traditional Chinese medicine recipe for curing various animal diarrhoeal diseases and preparation method of pure traditional Chinese medicine recipe | |
| CN103006758A (en) | Chinese medicament composition for treating infectious bursal disease and preparation method thereof | |
| CN101417018B (en) | Preparation method of animal injection capable of clearing away the heat-evil and expelling superficial evils, cooling blood and relieving dysentery | |
| CN102716214B (en) | Veterinary medicine composition for preventing and treating mycotoxin pathopoiesia | |
| CN105943629A (en) | Traditional Chinese medicine compound preparation for treating piglet diarrhea and preparation method thereof | |
| CN103202909B (en) | Traditional Chinese medicine feed additive for preventing and curing diarrhea of livestock and poultry as well as fur-bearing animals | |
| CN105535051A (en) | Pharmaceutical preparation for preventing and treating toxoplasmosis of pigs and preparation method of pharmaceutical preparation | |
| CN103877521A (en) | Pharmaceutical composition for preventing and treating chicken colibacillosis and preparation method of pharmaceutical composition | |
| CN104189167B (en) | A kind of treat cataplasma of piglet diarrhea and preparation method thereof | |
| CN102961563B (en) | Pharmaceutical composition for treating livestock and poultry dysentery and preparation method thereof | |
| CN101966201A (en) | Compound norfloxacin nicotinic soluble powder and preparation method thereof | |
| CN104000895B (en) | A kind of Chinese medicine extract of alternative antibiotic and preparation method and application | |
| CN114588206B (en) | Preparation for treating yellow and white scour of piglets by dark plum combined with mequindox and preparation method of preparation | |
| CN103520699B (en) | A kind of veterinary traditional Chinese medicine antiviral injection and preparation method thereof | |
| CN103585313A (en) | Compound Chinese-western powder for treating fish disease | |
| CN101264098A (en) | Medicinal composition for preventing and controlling livestock and fowls from infection disease | |
| CN108186750A (en) | A kind of Chinese medicine composition for preventing grice diarrhoea and its preparation method and application | |
| CN105560446A (en) | Medicinal preparation for preventing and curing mycoplasmosis of livestock and improving non-specific immunity and preparing method of medicinal preparation | |
| CN101264109A (en) | Medicinal composition for preventing and controlling pig diarrhea | |
| CN103316037A (en) | Mineral immunizing booster for treating swine diarrhea and improving swine production performance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160504 |
|
| WD01 | Invention patent application deemed withdrawn after publication |